QR-Code

Th1 Cytokine-Secreting Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and Prospective Use in Immunotherapy of Bladder Cancer

Intravesical instillation of Mycobacterium bovis bacillus Calmette-Guérin (BCG) has been used for treating bladder cancer for 3 decades. However, BCG therapy is ineffective in approximately 30–40% of cases. Since evidence supports the T helper type 1 (Th1) response to be essential in BCG-induced tum...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Yi Luo, Jonathan Henning, Michael A. O'Donnell
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2011-01-01
Schriftenreihe:Clinical and Developmental Immunology
Online-Zugang:http://dx.doi.org/10.1155/2011/728930
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!